Mackay Shields LLC’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-21,013
Closed -$5.1M 614
2022
Q1
$5.1M Sell
21,013
-751
-3% -$182K 0.04% 351
2021
Q4
$5.67M Sell
21,764
-490
-2% -$127K 0.05% 338
2021
Q3
$5.87M Sell
22,254
-644
-3% -$176K 0.06% 304
2021
Q2
$5.64M Sell
22,898
-1,368
-6% -$288K 0.05% 312
2021
Q1
$4.71M Sell
24,266
-107
-0.4% -$21.5K 0.03% 497
2020
Q4
$5.18M Sell
24,373
-16,620
-41% -$3.31M 0.04% 476
2020
Q3
$7.03M Buy
40,993
+14,495
+55% +$2.68M 0.05% 384
2020
Q2
$5.09M Sell
26,498
-2,790
-10% -$456K 0.04% 421
2020
Q1
$4.31M Sell
29,288
-18,906
-39% -$3.01M 0.04% 419
2019
Q4
$7.47M Buy
48,194
+17,337
+56% +$2.5M 0.05% 387
2019
Q3
$4.17M Buy
30,857
+9,111
+42% +$1.19M 0.03% 578
2019
Q2
$2.65M Sell
21,746
-8,212
-27% -$910K 0.02% 791
2019
Q1
$3.11M Sell
29,958
-8,236
-22% -$850K 0.02% 595
2018
Q4
$4.35M Sell
38,194
-4,453
-10% -$477K 0.04% 500
2018
Q3
$4.92M Sell
42,647
-54,939
-56% -$6.02M 0.04% 451
2018
Q2
$10.1M Buy
97,586
+73,505
+305% +$7.44M 0.07% 328
2018
Q1
$2.37M Buy
+24,081
New +$2.28M 0.01% 737

Other funds holding RMD

Mackay Shields LLC's RMD Position: Q2 2022 in Review

Mackay Shields LLC sold out of ResMed (RMD) in Q2 2022, closing a stake of 21,013 shares — an estimated $5.1M sold.

Mackay Shields LLC first reported a position in RMD in Q1 2018 and held it in 17 quarters. The position peaked at $10.1M in Q2 2018. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Mackay Shields LLC reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 21,013 ResMed shares in Q2 2022, an estimated $5.1M.
  • Mackay Shields LLC first reported a position in ResMed in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's ResMed position peaked at $10.1M in Q2 2018.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.